The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab
Status:
Unknown status
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
This is a three-year study to evaluate the effect of sequential therapy of Forteo
(teriparatide) and denosumab on bone density at the spine, hip, leg and forearm.